摘要
背景:肌营养不良是遗传性疾病,其特征为进行性骨骼肌变性,无需治愈性治疗。每种类型的肌营养不良的特定缺陷蛋白质与导致疾病进展的不同有害因素有关。在这些因素中,钙稳态,泛素 - 蛋白酶体功能障碍和细胞大分子的氧化损伤的损伤似乎是至关重要的。这些不同的细胞功能障碍是否通过对治疗敏感的常见致病机制相关联?先前已经提出了细胞半胱氨酸网络(CYSTEINET)作为互连的敏感的含半胱氨酸的蛋白质(SCCP)的基质,其除了反应性物质和半胱氨酸/谷胱甘肽循环之外可以通过复合物调节代谢,氧化还原和存活细胞途径生化网络的蛋白质具有不同的功能,但共享相同的调节巯基。 目的:由于有许多敏感的含半胱氨酸的蛋白质,包括半胱氨酸依赖性酶,易于在半胱氨酸残基的氧化还原修饰,这可能有助于肌肉变性,这项审查的目的是建议半胱氨酸调节异常可以解释氧化损伤,钙紊乱和泛素 - 蛋白酶体与肌营养不良相关的功能障碍。 结论:本评价提出在肌营养不良的半胱氨酸调节异常可能代表一个常见的致病网络,与特定的蛋白功能障碍,关联到肌肉变性。在这种情况下,N-乙酰半胱氨酸可以在与这些异质型疾病相关的所提出的半胱氨酸调节异常的恢复中具有重要作用。
关键词: 半胱氨酸,硫醇,谷胱甘肽,反应性物质,氧化还原稳态,肌营养不良,乙酰半胱氨酸,线粒体,半胱氨酸。
Current Medicinal Chemistry
Title:Cysteinet Dysregulation in Muscular Dystrophies: A Pathogenic Network Susceptible to Therapy
Volume: 24 Issue: 3
关键词: 半胱氨酸,硫醇,谷胱甘肽,反应性物质,氧化还原稳态,肌营养不良,乙酰半胱氨酸,线粒体,半胱氨酸。
摘要: Background: Muscular dystrophies are inherited disorders characterized by progressive skeletal muscle degeneration without curative therapy. The specific defective protein in each type of muscular dystrophy has been associated with different deleterious factors that contribute to the progression of the disease. Among these factors, the impairment of calcium homeostasis, the ubiquitin-proteasome dysfunction, and the oxidative damage of cellular macromolecules seem to be of central importance. Can these different cellular dysfunctions be linked by a common pathogenic mechanism susceptible to therapy? A cellular cysteine network (CYSTEINET) has been proposed previously, as a matrix of interconnected sensitive cysteine-containing proteins (SCCPs) that in addition to reactive species and the cysteine/glutathione cycles can regulate metabolic, redox, and survival cellular pathways by a complex biochemical network of proteins with different functions, but sharing the same regulatory thiol group.
Objective: Since there are many sensitive cysteine-containing proteins including cysteinedependent enzymes susceptible to redox modifications at cysteine residues that may contribute to muscular degeneration, the aim of this review is to propose that cysteinet dysregulation may explain oxidative damage, calcium disturbances and ubiquitin-proteasome dysfunctions associated with muscular dystrophies. Conclusion: The present review proposes that cysteinet dysregulation in muscular dystrophies may represent a common pathogenic network contributing, in association with the specific protein dysfunction, to muscular degeneration. In this context, N-acetylcysteine may have an important role in the restoration of the proposed cysteinet dysregulation associated with these heterogeneous types of diseases.Export Options
About this article
Cite this article as:
Cysteinet Dysregulation in Muscular Dystrophies: A Pathogenic Network Susceptible to Therapy, Current Medicinal Chemistry 2017; 24 (3) . https://dx.doi.org/10.2174/0929867323666161129124549
DOI https://dx.doi.org/10.2174/0929867323666161129124549 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Cilostazol in the Management of Atherosclerosis
Current Vascular Pharmacology New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Current Drug Targets Maintaining Plasma Fibrinogen Levels and Fibrinogen Replacement Therapies for Treatment of Intracranial Hemorrhage
Current Drug Targets Recent Advances in the Development of Multi-Kinase Inhibitors
Mini-Reviews in Medicinal Chemistry Association Between Anemia and Dementia: A Nationwide, Populationbased Cohort Study in Taiwan
Current Alzheimer Research Protective Effects of Melatonin and Mitochondria-targeted Antioxidants Against Oxidative Stress: A Review
Current Medicinal Chemistry Deep Brain Stimulation for Alzheimer’s Disease
Current Alzheimer Research Cell-and Gene-based Therapeutic Approaches for Neurological Deficits in Mucopolysaccharidoses
Current Pharmaceutical Biotechnology Histamine as a Potential Adjuvant to Immuno and Radiotherapy for Cancer Treatment: Discovering New Functions for the Oldest Biogenic Amine
Current Immunology Reviews (Discontinued) Restless Leg Syndrome Associated with Atypical Antipsychotics: Current Status, Pathophysiology, and Clinical Implications
Current Drug Safety Regenerative Potential of Stem Cells Derived from Human Exfoliated Deciduous (SHED) Teeth during Engineering of Human Body Tissues
Current Stem Cell Research & Therapy Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
Current Medicinal Chemistry Glial Cells – The Key Elements of Alzheimer´s Disease
Current Alzheimer Research Editorial (Thematic Issue: Central Nervous System Injuries: From Biology to Clinical Approaches)
Current Pharmaceutical Design Commentary: Neurorestoratology: A Concept and Emerging Discipline in the Treatment of Neurological Disorders
CNS & Neurological Disorders - Drug Targets Acid Sensing Ion Channels and Acid Nociception
Current Pharmaceutical Design Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats
CNS & Neurological Disorders - Drug Targets Programmed Cell Death after Intracerebral Hemorrhage
Current Neuropharmacology Neurorestorative Effect of Urinary Bladder Matrix-Mediated Neural Stem Cell Transplantation Following Traumatic Brain Injury in Rats
CNS & Neurological Disorders - Drug Targets